通过激素对治疗反应增强的PDT诱导的激活
Wojciech Domka1, Dorota Bartusik-Aebisher2, Maria Przygoda3
1Department of Otolaryngology, Medical College of the University of Rzeszów, 35-959 Rzeszów, Poland.
光动力疗法 (PDT) 触发了急性阶段反应,涉及影响癌症治疗的上腺皮质糖 (GCs). 了解GC调制可以提高癌症患者的PDT结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
背景情况:
- 光动力学疗法 (PDT) 使用光激活的光敏化剂,以向瘤细胞的破坏.
- PDT诱导急性阶段反应,涉及上腺糖皮质激素 (GC) 激素,这会影响癌症治疗的疗效.
- 接受PDT治疗的瘤的压力反应激活了下丘脑-垂体-上腺轴,导致GC释放.
研究的目的:
- 探索上腺皮质糖类 (GCs) 在光动力学疗法 (PDT) 诱导的抗癌效应的背景下的作用.
- 阐明由急性阶段反应驱动的GC调制如何影响癌症治疗结果.
主要方法:
- 该研究回顾了将PDT,急性期反应和GC释放联系在一起的生理机制.
- 在抗癌治疗期间,分析GCs在调节免疫和炎症细胞中的功能.
- 检查GCs在癌细胞中诱导亡的潜力.
主要成果:
- PDT激活荷尔蒙反应,特别是GC释放,这是其抗癌作用的组成部分.
- GCs动员中性粒细胞,刺激急性阶段试剂的产生,并调节免疫调节和炎症蛋白质.
- GCs具有影响炎症和免疫细胞活动的能力,并促进癌细胞亡.
结论:
- 上腺皮质糖类药物在光动力学治疗的全身效应中起着重要作用.
- 了解和潜在地调节GC活动可能代表一种新的策略,以改善PDT的癌症患者的结果.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:43Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy
Published on: April 28, 2022
相关概念视频
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Secondary Messengers in Hormone Action
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Regulation of Hormone Secretion
Humoral...
Hypothalamic-Pituitary Axis
GPCRs Regulate Adenylyl Cylase Activity
Sympathetic Activation
